# UCERIS
> **NDA205613** · New Drug Application · Sponsor: SALIX · Approved 2014-10-07
## Drug
- **FDA Application Number:** NDA205613
- **Application type:** New Drug Application
- **Brand name:** UCERIS
- **Generic name:** BUDESONIDE
- **Active ingredients:** BUDESONIDE
- **Dosage form:** AEROSOL, FOAM
- **Route:** RECTAL
- **Marketing status:** Prescription
- **Sponsor:** SALIX
- **Manufacturer:** Oceanside Pharmaceuticals
- **First approval:** 2014-10-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205613)
---
*AI Analytics · CC0 1.0*